【24h】

Primary gastric Iymphoma

机译:原发性胃淋巴瘤

获取原文
获取原文并翻译 | 示例
       

摘要

AIM: The purpose of this review is to describe the various aspects of primary gastric lymphoma and the treatment options currently available. METHODS: After a systematic search of Pubmed, Medscape and MDconsult, we reviewed and retrieved literature regarding gastric lymphoma. RESULTS: Primary gastric lymphoma is rare however, the incidence of this malignancy is increasing. Chronic gastritis secondary to Helicobacter pylori(H pylori) infection has been considered a major predisposing factor for MALT lymphoma. Immune histochemical marker studies and molecular biology utilizing polymerase chain reaction have facilitated appropriate diagnosis and abolished the need for diagnostic surgical resection. Advances in imaging techniques including Magnetic Resonance Imaging (MRI) and Endoscopic Ultrasonography (EUS) have helped evaluation of tumor extension and invasion. The clinical course and prognosis of this disease is dependent on histopathological sub-type and stage at the time of diagnosis. Controversy remains regarding the best treatment for early stages of this disease. Chemotherapy, surgery and combination have been studied and shared almost comparable results with survival rate of 70-90%. However, chemotherapy possesses the advantage of preserving gastric anatomy. Radiotherapy alone has been tried and showed good results. Stage IIIE, IVE disease treatment is solely by chemotherapy and surgical resection has been a remote consideration. CONCLUSION: We conclude that methods of diagnosis and staging of the primary gastric lymphoma have dramatically improved. The modalities of treatment are many and probably chemotherapy is superior because of high success rate, preservation of stomach and tolerable complications.
机译:目的:本综述旨在描述原发性胃淋巴瘤的各个方面以及目前可用的治疗方案。方法:在对Pubmed,Medscape和MDconsult进行系统搜索之后,我们回顾并检索了有关胃淋巴瘤的文献。结果:原发性胃淋巴瘤很少见,这种恶性肿瘤的发生率正在增加。继发于幽门螺杆菌(H pylori)感染的慢性胃炎被认为是MALT淋巴瘤的主要诱因。免疫组织化学标记物研究和利用聚合酶链反应的分子生物学已经促进了适当的诊断,并消除了诊断性手术切除的需要。包括磁共振成像(MRI)和内窥镜超声检查(EUS)在内的成像技术的进步有助于评估肿瘤的扩展和侵袭。该疾病的临床过程和预后取决于诊断时的组织病理学亚型和分期。关于该疾病早期的最佳治疗方法仍存在争议。化学疗法,外科手术和联合疗法已得到研究,并具有几乎可比的结果,存活率达70-90%。然而,化学疗法具有保留胃解剖学的优点。单独尝试放射治疗并显示出良好的效果。在IIIE期,IVE疾病仅通过化学疗法进行治疗,而手术切除一直是一个遥远的考虑因素。结论:我们得出结论,原发性胃淋巴瘤的诊断和分期方法已大大改善。治疗的方法很多,由于成功率高,保留胃和可耐受的并发症,化疗可能是更好的方法。

著录项

  • 来源
    《World Journal of Gastroenterology》 |2004年第1期|p.5-11|共7页
  • 作者单位

    Gastroenterology Division, Neelam Siddiqui, Oncology Division, Department of Medicine, College of Medicine and King Khalid University Hospital, King Saud University, Riyadh, Saudi Arabia;

  • 收录信息 美国《科学引文索引》(SCI);美国《工程索引》(EI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 消化系及腹部疾病;
  • 关键词

  • 入库时间 2022-08-17 23:37:34

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号